Sign in or create an account to add this stock to your watchlist.
About Inogen (NASDAQ:INGN)
Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. The company's oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; and Inogen At Home stationary oxygen concentrators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was founded in 2001 and is headquartered in Goleta, California.
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:INGN
CUSIPN/A
Phone805-562-0500
Debt
Debt-to-Equity RatioN/A
Current Ratio6.67
Quick Ratio6.06
Price-To-Earnings
Trailing P/E Ratio138.34
Forward P/E Ratio102.55
P/E Growth4.75
Sales & Book Value
Annual Sales$249.44 million
Price / Sales15.35
Cash Flow$1.8827 per share
Price / Cash95.86
Book Value$10.88 per share
Price / Book16.59
Profitability
EPS (Most Recent Fiscal Year)$1.31
Net Income$21 million
Net Margins9.36%
Return on Equity14.81%
Return on Assets12.19%
Miscellaneous
Employees770
Outstanding Shares21,220,000
Inogen (NASDAQ:INGN) Frequently Asked Questions
What is Inogen's stock symbol?
Inogen trades on the NASDAQ under the ticker symbol "INGN."
How were Inogen's earnings last quarter?
Inogen (NASDAQ:INGN) released its quarterly earnings data on Monday, April, 30th. The medical technology company reported $0.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.29 by $0.19. The medical technology company had revenue of $79.05 million for the quarter, compared to analyst estimates of $63.86 million. Inogen had a return on equity of 14.81% and a net margin of 9.36%. The firm's revenue for the quarter was up 50.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.27 EPS. View Inogen's Earnings History.
What price target have analysts set for INGN?
4 brokerages have issued twelve-month price objectives for Inogen's stock. Their forecasts range from $170.00 to $215.00. On average, they expect Inogen's share price to reach $188.75 in the next year. View Analyst Ratings for Inogen.
Who are some of Inogen's key competitors?
Some companies that are related to Inogen include Smith & Nephew (SNN), William Demant (WILYY), STERIS (STE), Mine Safety Appliances (MSA), Wright Medical Group (WMGI), Halyard Health (HYH), Consort Medical (CSRMY), Invacare (IVC), Sientra (SIEN), RTI Surgical (RTIX), Lakeland Industries (LAKE), ConforMIS (CFMS), Histogenics (HSGX), Rewalk Robotics (RWLK) and NanoVibronix (NAOV).
Who are Inogen's key executives?
Inogen's management team includes the folowing people:
- Mr. Scott Wilkinson, CEO, Pres & Director (Age 53)
- Mr. Brenton Taylor, Exec. VP of Engineering (Age 37)
- Ms. Alison Perry Bauerlein, Exec. VP of Fin., CFO, Sec. & Treasurer (Age 37)
- Mr. Matthew S. Scribner, Exec. VP of Operations (Age 51)
- Mr. Byron Myers, Exec. VP of Sales & Marketing (Age 39)
Has Inogen been receiving favorable news coverage?
Media stories about INGN stock have trended somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Inogen earned a news impact score of 0.08 on Accern's scale. They also assigned media coverage about the medical technology company an impact score of 46.20 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future.
Who are Inogen's major shareholders?
Inogen's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (11.40%), Blair William & Co. IL (2.68%), Dimensional Fund Advisors LP (2.32%), New York State Common Retirement Fund (1.72%), Rockefeller Capital Management L.P. (1.40%) and Wells Fargo & Company MN (1.40%). Company insiders that own Inogen stock include Alison Bauerlein, Brenton Taylor, Byron Myers, Heath Lukatch, Heather D Rider, Loren L Mcfarland, Matt Scribner, Ray Benjamin M Anderson, Raymond Huggenberger and Scott Wilkinson. View Institutional Ownership Trends for Inogen.
Which major investors are selling Inogen stock?
INGN stock was sold by a variety of institutional investors in the last quarter, including Blair William & Co. IL, Millennium Management LLC, Royal Bank of Canada, WINTON GROUP Ltd, Russell Investments Group Ltd., Dimensional Fund Advisors LP, Cortina Asset Management LLC and New York State Common Retirement Fund. Company insiders that have sold Inogen company stock in the last year include Alison Bauerlein, Brenton Taylor, Byron Myers, Heath Lukatch, Heather D Rider, Loren L Mcfarland, Matt Scribner, Ray Benjamin M Anderson, Raymond Huggenberger and Scott Wilkinson. View Insider Buying and Selling for Inogen.
Which major investors are buying Inogen stock?
INGN stock was acquired by a variety of institutional investors in the last quarter, including Rockefeller Capital Management L.P., Chicago Capital LLC, BlackRock Inc., Rock Springs Capital Management LP, Prudential Financial Inc., State of Wisconsin Investment Board, Wells Fargo & Company MN and OppenheimerFunds Inc.. View Insider Buying and Selling for Inogen.
How do I buy shares of Inogen?
Shares of INGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Inogen's stock price today?
One share of INGN stock can currently be purchased for approximately $180.48.
How big of a company is Inogen?
Inogen has a market capitalization of $3.98 billion and generates $249.44 million in revenue each year. The medical technology company earns $21 million in net income (profit) each year or $1.31 on an earnings per share basis. Inogen employs 770 workers across the globe.
How can I contact Inogen?
Inogen's mailing address is 326 BOLLAY DRIVE, GOLETA CA, 93117. The medical technology company can be reached via phone at 805-562-0500 or via email at [email protected]
MarketBeat Community Rating for Inogen (INGN)
MarketBeat's community ratings are surveys of what our community members think about Inogen and other stocks. Vote "Outperform" if you believe INGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INGN will underperform the S&P 500 over the long term. You may vote once every thirty days.
Inogen (NASDAQ:INGN) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
4 Wall Street analysts have issued ratings and price targets for Inogen in the last 12 months. Their average twelve-month price target is $188.75, suggesting that the stock has a possible upside of 4.58%. The high price target for INGN is $215.00 and the low price target for INGN is $170.00. There are currently 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 3.25 | 2.80 | 2.83 | 2.67 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
1 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
1 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
1 Strong Buy Rating(s) |
| Consensus Price Target: | $188.75 | $118.40 | $98.50 | $98.50 |
| Price Target Upside: | 4.58% upside | 14.77% downside | 20.86% downside | 16.61% downside |
Inogen (NASDAQ:INGN) Consensus Price Target History
Inogen (NASDAQ:INGN) Analyst Ratings History
Show:
(Data available from 5/21/2016 forward)
Inogen (NASDAQ:INGN) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Inogen (NASDAQ INGN) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 5.29%
Institutional Ownership Percentage: 99.23%
Inogen (NASDAQ INGN) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 5/11/2018 | Loren L Mcfarland | Director | Sell | 2,125 | $181.44 | $385,560.00 | 3,114 |  |
| 5/1/2018 | Scott Wilkinson | Insider | Sell | 9,198 | $170.35 | $1,566,879.30 | | |
| 4/17/2018 | Ray Benjamin M Anderson | Director | Sell | 1,000 | $139.82 | $139,820.00 | 1,000 | |
| 4/16/2018 | Matt Scribner | EVP | Sell | 2,500 | $139.79 | $349,475.00 | 8,374 | |
| 3/15/2018 | Matt Scribner | EVP | Sell | 2,500 | $127.95 | $319,875.00 | | |
| 3/8/2018 | Alison Bauerlein | EVP | Sell | 15,911 | $124.48 | $1,980,601.28 | 20,072 | |
| 3/1/2018 | Heath Lukatch | Director | Sell | 2,500 | $119.15 | $297,875.00 | 2,500 | |
| 2/26/2018 | Heather D Rider | Director | Sell | 5,222 | $131.13 | $684,760.86 | 3,222 | |
| 2/21/2018 | Brenton Taylor | EVP | Sell | 5,000 | $130.76 | $653,800.00 | 38,982 | |
| 2/20/2018 | Alison Bauerlein | CFO | Sell | 3,192 | $125.41 | $400,308.72 | 8,808 | |
| 2/16/2018 | Alison Bauerlein | CFO | Sell | 8,808 | $125.03 | $1,101,264.24 | 8,808 | |
| 2/16/2018 | Brenton Taylor | EVP | Sell | 5,000 | $125.06 | $625,300.00 | 38,982 | |
| 2/14/2018 | Alison Bauerlein | CFO | Sell | 9,737 | $120.05 | $1,168,926.85 | 9,737 | |
| 2/14/2018 | Brenton Taylor | EVP | Sell | 15,000 | $117.47 | $1,762,050.00 | 38,982 | |
| 2/12/2018 | Alison Bauerlein | EVP | Sell | 27,630 | $116.46 | $3,217,789.80 | 11,718 | |
| 2/9/2018 | Alison Bauerlein | CFO | Sell | 11,718 | $115.87 | $1,357,764.66 | 11,718 | |
| 1/16/2018 | Matt Scribner | EVP | Sell | 2,500 | $116.17 | $290,425.00 | 7,297 | |
| 1/16/2018 | Raymond Huggenberger | Director | Sell | 13,000 | $116.19 | $1,510,470.00 | 10,208 | |
| 1/16/2018 | Scott Wilkinson | Insider | Sell | 30,651 | $115.75 | $3,547,853.25 | 38,107 | |
| 1/2/2018 | Ray Benjamin M Anderson | Director | Sell | 1,000 | $119.06 | $119,060.00 | 1,000 | |
| 12/15/2017 | Raymond Huggenberger | Director | Sell | 14,000 | $119.92 | $1,678,880.00 | 7,808 | |
| 12/14/2017 | Matt Scribner | EVP | Sell | 2,500 | $120.34 | $300,850.00 | 7,297 | |
| 12/11/2017 | Byron Myers | EVP | Sell | 10,000 | $116.81 | $1,168,100.00 | 48,600 | |
| 12/1/2017 | Heath Lukatch | Director | Sell | 2,500 | $126.40 | $316,000.00 | | |
| 11/17/2017 | Byron Myers | EVP | Sell | 35,000 | $116.77 | $4,086,950.00 | 48,600 | |
| 11/13/2017 | Matt Scribner | EVP | Sell | 2,500 | $112.35 | $280,875.00 | | |
| 10/16/2017 | Raymond Huggenberger | Director | Sell | 14,000 | $94.07 | $1,316,980.00 | 7,808 | |
| 10/12/2017 | Matt Scribner | EVP | Sell | 2,500 | $93.88 | $234,700.00 | | |
| 10/10/2017 | Alison Bauerlein | EVP | Sell | 15,000 | $94.93 | $1,423,950.00 | | |
| 9/15/2017 | Raymond Huggenberger | Director | Sell | 14,000 | $102.30 | $1,432,200.00 | 7,808 | |
| 9/11/2017 | Matt Scribner | EVP | Sell | 2,500 | $103.23 | $258,075.00 | 6,964 | |
| 9/6/2017 | Heath Lukatch | Director | Sell | 2,500 | $97.44 | $243,600.00 | 2,500 | |
| 8/18/2017 | Matt Scribner | EVP | Sell | 2,500 | $92.45 | $231,125.00 | 6,964 | |
| 8/15/2017 | Raymond Huggenberger | Director | Sell | 14,000 | $91.67 | $1,283,380.00 | 7,808 | |
| 8/10/2017 | Alison Bauerlein | EVP | Sell | 6,667 | $92.64 | $617,630.88 | 15,000 | |
| 7/18/2017 | Matt Scribner | EVP | Sell | 2,500 | $94.21 | $235,525.00 | 4,833 | |
| 7/14/2017 | Raymond Huggenberger | Director | Sell | 14,000 | $92.96 | $1,301,440.00 | 7,808 | |
| 6/16/2017 | Matt Scribner | EVP | Sell | 2,500 | $91.54 | $228,850.00 | 4,833 | |
| 6/15/2017 | Raymond Huggenberger | Director | Sell | 15,300 | $90.88 | $1,390,464.00 | 7,808 | |
| 6/2/2017 | Byron Myers | EVP | Sell | 10,000 | $90.00 | $900,000.00 | 45,185 | |
| 6/1/2017 | Scott Wilkinson | Insider | Sell | 23,437 | $88.06 | $2,063,862.22 | 54,088 | |
| 5/30/2017 | Heath Lukatch | Director | Sell | 9,000 | $88.52 | $796,680.00 | 7,246 | |
| 5/18/2017 | Ray Benjamin M Anderson | Director | Sell | 4,445 | $81.05 | $360,267.25 | 4,445 | |
| 5/10/2017 | Alison Bauerlein | EVP | Sell | 6,666 | $83.24 | $554,877.84 | 25,758 | |
| 4/24/2017 | Byron Myers | EVP | Sell | 10,000 | $80.00 | $800,000.00 | 45,185 | |
| 4/17/2017 | Matt Scribner | EVP | Sell | 2,500 | $75.28 | $188,200.00 | 4,064 | |
| 3/15/2017 | Matt Scribner | EVP | Sell | 2,500 | $73.85 | $184,625.00 | 4,833 | |
| 2/28/2017 | Brenton Taylor | EVP | Sell | 3,750 | $70.07 | $262,762.50 | 31,851 | |
| 1/17/2017 | Matt Scribner | EVP | Sell | 2,500 | $63.91 | $159,775.00 | 4,833 | |
| 1/17/2017 | Raymond Huggenberger | CEO | Sell | 5,680 | $63.96 | $363,292.80 | 12,488 | |
| 1/10/2017 | Brenton Taylor | EVP | Sell | 5,105 | $65.31 | $333,407.55 | 31,851 | |
| 1/3/2017 | Brenton Taylor | EVP | Sell | 31,823 | $65.69 | $2,090,452.87 | 63,674 | |
| 12/15/2016 | Raymond Huggenberger | CEO | Sell | 8,000 | $65.59 | $524,720.00 | 14,808 | |
| 12/14/2016 | Matt Scribner | EVP | Sell | 2,500 | $65.13 | $162,825.00 | 4,833 | |
| 12/1/2016 | Scott Wilkinson | Insider | Sell | 26,706 | $61.64 | $1,646,157.84 | 66,050 | |
| 11/14/2016 | Matt Scribner | EVP | Sell | 2,500 | $63.80 | $159,500.00 | 4,833 | |
| 10/17/2016 | Raymond Huggenberger | CEO | Sell | 7,089 | $56.24 | $398,685.36 | 8,342 | |
| 10/12/2016 | Matt Scribner | EVP | Sell | 4,551 | $59.45 | $270,556.95 | 6,884 | |
| 9/19/2016 | Matt Scribner | EVP | Sell | 4,551 | $60.18 | $273,879.18 | 6,884 | |
| 9/16/2016 | Byron Myers | VP | Sell | 6,200 | $60.04 | $372,248.00 | 41,385 | |
| 9/9/2016 | Byron Myers | VP | Sell | 3,800 | $60.07 | $228,266.00 | 35,585 | |
| 8/18/2016 | Matt Scribner | EVP | Sell | 2,320 | $56.39 | $130,824.80 | 4,653 | |
| 8/15/2016 | Raymond Huggenberger | CEO | Sell | 20,747 | $57.48 | $1,192,537.56 | 27,555 | |
| 8/9/2016 | Byron Myers | VP | Sell | 13,000 | $55.00 | $715,000.00 | 35,185 | |
| 7/18/2016 | Matt Scribner | EVP | Sell | 4,102 | $50.46 | $206,986.92 | 6,435 | |
| 7/18/2016 | Raymond Huggenberger | CEO | Sell | 20,747 | $50.41 | $1,045,856.27 | 27,555 | |
| 6/16/2016 | Matt Scribner | EVP | Sell | 4,102 | $47.66 | $195,501.32 | 2,738 | |
| 6/16/2016 | Raymond Huggenberger | CEO | Sell | 20,747 | $47.86 | $992,951.42 | 27,555 | |
| 5/16/2016 | Matt Scribner | EVP | Sell | 4,102 | $43.82 | $179,749.64 | 6,435 | |
| 5/16/2016 | Raymond Huggenberger | CEO | Sell | 20,746 | $44.18 | $916,558.28 | 27,554 | |
| 4/15/2016 | Matt Scribner | EVP | Sell | 4,102 | $48.62 | $199,439.24 | 6,435 | |
| 4/15/2016 | Raymond Huggenberger | CEO | Sell | 29,635 | $48.59 | $1,439,964.65 | 25,210 | |
| 4/13/2016 | Brenton Taylor | EVP | Sell | 6,500 | $48.00 | $312,000.00 | 31,851 | |
| 4/6/2016 | Alison Bauerlein | CFO | Sell | 9,278 | $46.18 | $428,458.04 | 38,332 | |
| 3/31/2016 | Alison Bauerlein | CFO | Sell | 4,360 | $44.33 | $193,278.80 | 48,332 | |
| 2/16/2016 | Matt Scribner | EVP | Sell | 4,102 | $30.26 | $124,126.52 | 2,333 | |
| 1/14/2016 | Matt Scribner | EVP | Sell | 4,102 | $34.73 | $142,462.46 | 2,333 | |
| 12/14/2015 | Matt Scribner | EVP | Sell | 4,102 | $40.40 | $165,720.80 | 2,333 | |
| 11/12/2015 | Matt Scribner | EVP | Sell | 4,102 | $44.52 | $182,621.04 | 2,333 | |
| 10/26/2015 | Brenton Taylor | EVP | Sell | 5,000 | $41.38 | $206,900.00 | 43,351 | |
| 10/21/2015 | Raymond Huggenberger | CEO | Sell | 57,418 | $43.06 | $2,472,419.08 | 6,808 | |
| 10/12/2015 | Matt Scribner | EVP | Sell | 4,102 | $44.06 | $180,734.12 | 2,333 | |
| 10/1/2015 | Alison Bauerlein | CFO | Sell | 10,185 | $47.94 | $488,268.90 | 43,890 | |
| 9/25/2015 | Brenton Taylor | EVP | Sell | 3,333 | $53.48 | $178,248.84 | 43,351 | |
| 9/16/2015 | Byron Myers | VP | Sell | 1,700 | $55.00 | $93,500.00 | 36,332 | |
| 9/15/2015 | Raymond Huggenberger | CEO | Sell | 57,416 | $53.58 | $3,076,349.28 | 6,808 | |
| 9/14/2015 | Byron Myers | VP | Sell | 7,950 | $55.23 | $439,078.50 | 36,332 | |
| 9/10/2015 | Matt Scribner | EVP | Sell | 4,102 | $53.30 | $218,636.60 | 4,666 | |
| 9/1/2015 | Alison Bauerlein | CFO | Sell | 6,500 | $48.21 | $313,365.00 | 49,075 | |
| 8/26/2015 | Scott Wilkinson | EVP | Sell | 6,666 | $45.42 | $302,769.72 | | |
| 8/25/2015 | Brenton Taylor | EVP | Sell | 3,333 | $46.84 | $156,117.72 | 46,684 | |
| 8/25/2015 | Ray Benjamin M. Anderson | Director | Sell | 5,658 | $46.36 | $262,304.88 | 4,896 | |
| 5/28/2015 | Timothy Petersen | Director | Sell | 337,081 | $37.44 | $12,620,312.64 | | |
| 5/26/2015 | Timothy Petersen | Director | Sell | 54,258 | $37.05 | $2,010,258.90 | | |
| 5/22/2015 | Timothy Petersen | Director | Sell | 86,889 | $37.09 | $3,222,713.01 | | |
| 5/21/2015 | Timothy Petersen | Director | Sell | 134,300 | $37.81 | $5,077,883.00 | | |
| 5/19/2015 | Timothy Petersen | Director | Sell | 115,700 | $37.25 | $4,309,825.00 | | |
| 5/18/2015 | Timothy Petersen | Director | Sell | 58,987 | $37.35 | $2,203,164.45 | | |
| 3/5/2015 | Matt Scribner | EVP | Sell | 4,102 | $33.69 | $138,196.38 | | |
| 2/25/2015 | Brenton Taylor | EVP | Sell | 15,687 | $33.87 | $531,318.69 | | |
| 2/23/2015 | Alison Bauerlein | CFO | Sell | 15,687 | $33.10 | $519,239.70 | | |
| 2/19/2015 | Raymond Huggenberger | CEO | Sell | 25,722 | $33.95 | $873,261.90 | | |
| 2/13/2015 | Scott Wilkinson | EVP | Sell | 18,333 | $32.87 | $602,605.71 | | |
| 2/5/2015 | Matt Scribner | EVP | Sell | 4,102 | $30.66 | $125,767.32 | | |
| 2/3/2015 | Timothy Petersen | Director | Sell | 17,000 | $30.25 | $514,250.00 | | |
| 2/2/2015 | Timothy Petersen | Director | Sell | 99,000 | $30.88 | $3,057,120.00 | | |
| 1/29/2015 | Timothy Petersen | Director | Sell | 601,000 | $31.95 | $19,201,950.00 | | |
| 1/26/2015 | Brenton Taylor | EVP | Sell | 15,687 | $31.53 | $494,611.11 | | |
| 1/23/2015 | Alison Bauerlein | CFO | Sell | 15,687 | $31.53 | $494,611.11 | | |
| 1/20/2015 | Raymond Huggenberger | CEO | Sell | 25,722 | $31.63 | $813,586.86 | | |
| 1/5/2015 | Matt Scribner | EVP | Sell | 4,102 | $31.14 | $127,736.28 | | |
| 1/5/2015 | Versant Ventures Ii Llc | Major Shareholder | Sell | 7,946 | $30.98 | $246,167.08 | | |
| 12/30/2014 | Scott Wilkinson | EVP | Sell | 962 | $30.50 | $29,341.00 | | |
| 12/29/2014 | Scott Wilkinson | EVP | Sell | 15,735 | $30.52 | $480,232.20 | | |
| 12/24/2014 | Byron Myers | VP | Sell | 7,514 | $30.07 | $225,945.98 | | |
| 12/23/2014 | Alison Bauerlein | CFO | Sell | 15,687 | $29.85 | $468,256.95 | | |
| 12/23/2014 | Byron Myers | VP | Sell | 3,018 | $30.04 | $90,660.72 | | |
| 12/23/2014 | Versant Ventures Ii Llc | Major Shareholder | Sell | 9,785 | $29.74 | $291,005.90 | | |
| 12/22/2014 | Byron Myers | VP | Sell | 11,801 | $30.06 | $354,738.06 | | |
| 12/22/2014 | Scott Wilkinson | EVP | Sell | 1,033 | $30.31 | $31,310.23 | | |
| 12/19/2014 | Raymond Huggenberger | CEO | Sell | 25,722 | $28.98 | $745,423.56 | | |
| 12/11/2014 | Scott Wilkinson | EVP | Sell | 14,700 | $25.25 | $371,175.00 | | |
| 12/3/2014 | Matt Scribner | EVP | Sell | 4,102 | $24.09 | $98,817.18 | | |
| 11/25/2014 | Brenton Taylor | EVP | Sell | 15,687 | $24.71 | $387,625.77 | | |
| 11/21/2014 | Alison Bauerlein | CFO | Sell | 15,687 | $24.49 | $384,174.63 | | |
| 11/19/2014 | Raymond Huggenberger | CEO | Sell | 25,722 | $24.25 | $623,758.50 | | |
| 11/19/2014 | Versant Ventures Ii Llc | Major Shareholder | Sell | 28,225 | $24.77 | $699,133.25 | | |
| 11/18/2014 | Scott Wilkinson | EVP | Sell | 2,233 | $25.21 | $56,293.93 | | |
| 11/18/2014 | Versant Ventures Ii Llc | Major Shareholder | Sell | 11,848 | $24.83 | $294,185.84 | | |
| 11/17/2014 | Versant Ventures Ii Llc | Major Shareholder | Sell | 5,343 | $24.89 | $132,987.27 | | |
| 11/14/2014 | Heather D Rider | Director | Buy | 3,000 | $25.00 | $75,000.00 | | |
| 11/14/2014 | Scott Wilkinson | EVP | Sell | 1,100 | $25.15 | $27,665.00 | | |
| 11/14/2014 | Versant Ventures Ii Llc | Major Shareholder | Sell | 9,433 | $25.13 | $237,051.29 | | |
| 11/10/2014 | Versant Ventures Ii Llc | Major Shareholder | Sell | 2,992 | $24.42 | $73,064.64 | | |
| 11/7/2014 | Versant Ventures Ii Llc | Major Shareholder | Sell | 7,388 | $24.30 | $179,528.40 | | |
| 11/4/2014 | A/S Novo | Major Shareholder | Sell | 2,000,000 | $21.50 | $43,000,000.00 | | |
| 11/4/2014 | Raymond Huggenberger | CEO | Sell | 165,891 | $20.21 | $3,352,657.11 | | |
| 11/4/2014 | Timothy Petersen | Director | Sell | 250,000 | $21.50 | $5,375,000.00 | | |
| 11/3/2014 | Matt Scribner | EVP | Sell | 4,102 | $24.08 | $98,776.16 | | |
| 10/29/2014 | Scott Wilkinson | EVP | Sell | 18,333 | $22.41 | $410,842.53 | | |
| 10/27/2014 | Brenton Taylor | EVP | Sell | 15,687 | $21.67 | $339,937.29 | | |
| 10/24/2014 | Versant Ventures Ii Llc | Major Shareholder | Sell | 4,647 | $20.76 | $96,471.72 | | |
| 10/23/2014 | Alison Bauerlein | CFO | Sell | 15,687 | $20.50 | $321,583.50 | | |
| 10/9/2014 | Versant Ventures Ii Llc | Major Shareholder | Sell | 1,900 | $20.83 | $39,577.00 | | |
| 10/8/2014 | Versant Ventures Ii Llc | Major Shareholder | Sell | 6,907 | $21.03 | $145,254.21 | | |
| 10/7/2014 | Timothy Petersen | Director | Sell | 31,600 | $21.55 | $680,980.00 | | |
| 10/6/2014 | Timothy Petersen | Director | Sell | 17,475 | $21.56 | $376,761.00 | | |
| 10/3/2014 | Timothy Petersen | Director | Sell | 31,658 | $21.52 | $681,280.16 | | |
| 10/3/2014 | Ventures Lp Arboretum II | Major Shareholder | Sell | 98,400 | $20.97 | $2,063,448.00 | | |
| 10/2/2014 | Timothy Petersen | Director | Sell | 24,597 | $20.91 | $514,323.27 | | |
| 10/1/2014 | Matt Scribner | EVP | Sell | 8,204 | $20.25 | $166,131.00 | | |
| 10/1/2014 | Timothy Petersen | Director | Sell | 42,145 | $20.61 | $868,608.45 | | |
| 9/30/2014 | Timothy Petersen | Director | Sell | 84,500 | $20.23 | $1,709,435.00 | | |
| 9/24/2014 | Ventures Lp Arboretum II | Major Shareholder | Sell | 83,500 | $20.34 | $1,698,390.00 | | |
| 9/23/2014 | Alison Bauerlein | CFO | Sell | 15,687 | $20.01 | $313,896.87 | | |
| 9/22/2014 | Raymond Huggenberger | CEO | Sell | 25,722 | $20.25 | $520,870.50 | | |
| 9/22/2014 | Timothy Petersen | Director | Sell | 46,865 | $21.05 | $986,508.25 | | |
| 9/17/2014 | Timothy Petersen | Director | Sell | 39,135 | $21.72 | $850,012.20 | | |
| 9/17/2014 | Ventures Lp Arboretum II | Major Shareholder | Sell | 55,135 | $21.61 | $1,191,467.35 | | |
| 9/16/2014 | Timothy Petersen | Director | Sell | 6,500 | $21.16 | $137,540.00 | | |
| 9/15/2014 | Byron Myers | VP | Sell | 22,333 | $21.33 | $476,362.89 | | |
| 9/15/2014 | Scott Wilkinson | EVP | Sell | 18,333 | $21.42 | $392,692.86 | | |
| 9/15/2014 | Timothy Petersen | Director | Sell | 9,500 | $21.45 | $203,775.00 | | |
| 9/9/2014 | Versant Ventures Ii Llc | Major Shareholder | Sell | 7,388 | $23.25 | $171,771.00 | | |
| 3/7/2014 | Charles E Larsen | Director | Sell | 26,201 | $14.88 | $389,870.88 | | |
| 2/20/2014 | A/S Novo | Insider | Sell | 617,000 | $14.88 | $9,180,960.00 | | |
| 2/20/2014 | Loren L Mcfarland | Director | Buy | 3,125 | $16.00 | $50,000.00 | | |
(Data available from 1/1/2013 forward)
Inogen (NASDAQ INGN) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Inogen (INGN) Expected to Announce Earnings of $0.44 Per Share
www.americanbankingnews.com - May 20 at 9:54 AM |
| Loren L. Mcfarland Sells 2,125 Shares of Inogen (INGN) Stock
www.americanbankingnews.com - May 15 at 10:10 PM |
| Inogen (INGN) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 7 at 9:13 AM |
| $79.47 Million in Sales Expected for Inogen (INGN) This Quarter
www.americanbankingnews.com - May 4 at 2:10 AM |
| Inogen (INGN) Upgraded to "Strong-Buy" at ValuEngine
www.americanbankingnews.com - May 3 at 10:34 PM |
| Inogen (INGN) Insider Scott Wilkinson Sells 9,198 Shares
www.americanbankingnews.com - May 3 at 7:33 PM |
| Piper Jaffray Analysts Raise Earnings Estimates for Inogen (INGN)
www.americanbankingnews.com - May 3 at 9:30 AM |
| Q2 2018 EPS Estimates for Inogen (INGN) Boosted by Leerink Swann
www.americanbankingnews.com - May 3 at 7:44 AM |
| William Blair Comments on Inogen's Q2 2018 Earnings (INGN)
www.americanbankingnews.com - May 3 at 7:44 AM |
| Zacks: Analysts Anticipate Inogen (INGN) to Announce $0.46 Earnings Per Share
www.americanbankingnews.com - May 2 at 9:58 PM |
 | Inogen Continues To Generate Some Of The Best Growth In Med-Tech
seekingalpha.com - May 2 at 4:50 PM |
| Leerink Swann Equities Analysts Increase Earnings Estimates for Inogen (INGN)
www.americanbankingnews.com - May 2 at 10:00 AM |
| Inogen Forecasted to Earn Q3 2018 Earnings of $0.51 Per Share (INGN)
www.americanbankingnews.com - May 2 at 9:22 AM |
 | Today’s Research Reports on Stocks to Watch: Tenet Healthcare and Inogen
finance.yahoo.com - May 2 at 9:05 AM |
| Piper Jaffray Equities Analysts Lower Earnings Estimates for Inogen (INGN)
www.americanbankingnews.com - May 2 at 9:05 AM |
 | US STOCKS ON THE MOVE-Apple, Pfizer, Karyopharm, Tapestry, Inogen, Seagate, steel stocks
www.nasdaq.com - May 1 at 4:39 PM |
| Inogen Inc. (INGN) Has Jumped To A New High After Strong Q1 Report
www.nasdaq.com - May 1 at 4:39 PM |
| Inogen, Inc 2018 Q1 - Results - Earnings Call Slides
seekingalpha.com - May 1 at 4:39 PM |
 | Mid-Afternoon Market Update: NASDAQ Up 0.5%; Inogen Shares Spike Higher
feeds.benzinga.com - May 1 at 4:10 PM |
| Inogen Q1 revenue up 51%; earnings up 83%; guidance raised; shares up 18%
seekingalpha.com - May 1 at 2:31 PM |
| Leerink Swann Reiterates "Outperform" Rating for Inogen (INGN)
www.americanbankingnews.com - May 1 at 9:13 AM |
 | Top Analyst Upgrades and Downgrades: AK Steel, Arconic, Facebook, Inogen, Roku, Sprint, SteadyMed and More
247wallst.com - May 1 at 9:09 AM |
 | Inogen (INGN) Beats Q1 Earnings Estimates, Lifts 2018 View
www.zacks.com - May 1 at 9:09 AM |
| Benzinga's Daily Biotech Pulse: Karyopharm's STORM Study, Inogen Rallies On Earnings
www.benzinga.com - May 1 at 9:09 AM |
| Inogen's (INGN) CEO Scott Wilkinson on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 1 at 9:09 AM |
| Edited Transcript of INGN earnings conference call or presentation 30-Apr-18 8:30pm GMT
finance.yahoo.com - May 1 at 9:09 AM |
| JPMorgan Chase Reiterates "Overweight" Rating for Inogen (INGN)
www.americanbankingnews.com - May 1 at 9:08 AM |
| Inogen (INGN) Price Target Raised to $215.00
www.americanbankingnews.com - May 1 at 8:38 AM |
| Inogen (INGN) Releases Quarterly Earnings Results, Beats Estimates By $0.19 EPS
www.americanbankingnews.com - April 30 at 9:16 PM |
| Inogen (INGN) Price Target Increased to $190.00 by Analysts at Piper Jaffray
www.americanbankingnews.com - April 30 at 9:10 PM |
| Inogen beats by $0.19, beats on revenue
seekingalpha.com - April 30 at 4:46 PM |
 | BRIEF-Inogen Q1 Earnings Per Share $0.48
www.reuters.com - April 30 at 4:41 PM |
| Inogen Announces Record First Quarter 2018 Financial Results and Increases 2018 Guidance
finance.yahoo.com - April 30 at 4:41 PM |
| Inogen: 1Q Earnings Snapshot
finance.yahoo.com - April 30 at 4:41 PM |
| What's in the Cards for Inogen (INGN) This Earnings Season?
www.zacks.com - April 25 at 4:52 PM |
| What's in the Cards for Inogen (INGN) This Earnings Season?
finance.yahoo.com - April 25 at 4:52 PM |
| Inogen (INGN) Set to Announce Quarterly Earnings on Monday
www.americanbankingnews.com - April 23 at 8:16 PM |
| Ray Benjamin M. Anderson Sells 1,000 Shares of Inogen (INGN) Stock
www.americanbankingnews.com - April 19 at 7:36 PM |
| Inogen to Announce First Quarter 2018 Financial Results on Monday, April 30, 2018
finance.yahoo.com - April 19 at 4:55 PM |
| Head-To-Head Survey: Align Technology (ALGN) and Inogen (INGN)
www.americanbankingnews.com - April 18 at 11:08 PM |
 | Form 4 Inogen Inc For: Apr 16 Filed by: Scribner Matt
www.streetinsider.com - April 18 at 5:01 PM |
| Matt Scribner Sells 2,500 Shares of Inogen (INGN) Stock
www.americanbankingnews.com - April 17 at 10:33 PM |
| Inogen (INGN) Expected to Post Quarterly Sales of $62.60 Million
www.americanbankingnews.com - April 17 at 2:32 AM |
| Invacare (IVC) & Inogen (INGN) Head-To-Head Contrast
www.americanbankingnews.com - April 15 at 7:19 PM |
| $0.27 EPS Expected for Inogen (INGN) This Quarter
www.americanbankingnews.com - April 15 at 7:18 PM |
| Piper Jaffray Reiterates $145.00 Price Target for Inogen (INGN)
www.americanbankingnews.com - April 15 at 8:35 AM |
| Inogen (INGN) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - April 14 at 10:53 PM |
| Health Care Sector Update for 04/13/2018: CDNA,PLSE,IPCT,INGN
www.nasdaq.com - April 13 at 4:47 PM |
| Oxygen device maker Inogen discloses customer data breach
finance.yahoo.com - April 13 at 4:47 PM |
| Inogen discloses data breach
www.nasdaq.com - April 13 at 9:23 AM |
Inogen (NASDAQ:INGN) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Inogen (NASDAQ:INGN) Income Statement, Balance Sheet and Cash Flow Statement
Inogen (NASDAQ INGN) Stock Chart for Monday, May, 21, 2018
Loading chart…
